Clinical trial Recruiting at 1 site Interventional Ages 41 to 65

Adding an anterior capsular block to a steroid injection for frozen shoulder pain

Official title: Comparative Study Between Shoulder Anterior Capsular Block Plus Steroid Injection Versus Steroid Injection Alone for Pain Management in Adhesive Capsulitis: A Randomized Trial

Run by Zagazig University · NCT07235982 · Data updated 2026-11-12

This test will see if adding an anterior capsular block to an intraarticular steroid injection gives better and longer pain relief for people aged 41–65 with adhesive capsulitis.

More Analgesia trials

Quick facts

Study typeInterventional
Ages41 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorZagazig University
Government
Locations1 site (Zagazig)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMay 1, 2026
Study endsJune 1, 2026
Registry record updatedNovember 19, 2025
Trial IDNCT07235982 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 41–65 with adhesive capsulitis who are ASA I–II, have had at least two weeks of failed conservative treatment, and have no secondary shoulder pathology or contraindications to regional block or steroids.

Probably not a fit

Patients with secondary shoulder disorders, contraindications to regional blocks or steroid/bupivacaine allergy, advanced uncontrolled systemic disease, or prior surgery/neuropathy in the involved limb are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with adhesive capsulitis will receive either a combined shoulder anterior capsular block plus intraarticular steroid injection or an intraarticular steroid injection alone and will be followed for eight weeks. Pain will be tracked with a Visual Analogue Scale at baseline and during follow-up, and total rescue ibuprofen use will be recorded. Secondary measures include the Shoulder Pain and Disability Index, recording of block- or injection-related complications, and a five-point patient satisfaction rating. The procedures are performed at a single center (Zagazig University Faculty of Medicine) by clinical staff experienced in injections and regional blocks.

Why it matters

Potential benefit: If successful, patients could gain faster or greater pain relief and reduce their need for additional pain medication.

How similar studies have gone: Intraarticular steroids and regional shoulder blocks have both shown short-term pain relief in prior work, but direct evidence on combining an anterior capsular block with steroid injection for adhesive capsulitis is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients acceptance
* Age: 41-65 years old
* Sex: both sex (males or females).
* Physical status: American Society of Anesthesiologist (ASA) І, II.
* Patients attend orthopedic or pain clinic with complaint of shoulder pain and stiffness. These patients received conservative management of pain with no relief of symptoms for at least 2 weeks.

Exclusion Criteria:

* Shoulder pain due to secondary causes, e.g. acute trauma, fractures, bony deformity, glenohumeral joint pathology, acromioclavicular joint pathology and rotator cuff disorder.

  * Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
  * Patients with known history of allergy to the study drugs (bupivacaine and methylprednisolone).
  * Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases, uncontrolled diabetes mellitus and thyroid.
  * History of neuropathy in the involved limb or previous revision surgery.

Where it's running

  • Faculity of Medicine, Zagazig University
    Zagazig, Egypt
    Recruiting

Study contacts

  • Principal investigator: Dina Salem, MD — Faculty of Medicine, Zagazig University
  • Study coordinator: Dina Salem, MD
  • Email: dinamaghraby@yahoo.com
  • Phone: 01099333513

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.